Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05397171
Title A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site Providence Rhode Island 02903 United States Details
Research Site Seattle Washington 98109 United States Details
Research Site Ottawa Ontario K1H 8L6 Canada Details
Research Site Toronto Ontario M5G 1X5 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field